Management of epidermolysis bullosa in infants and children

Clinics in Dermatology

Volumn 21, Issue 4, 2003, Pages 278-282

  Bello, Ysabel M ^b   Falabella, Anna F ^b   Schachner, Lawrence A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; BACITRACIN; CHLORHEXIDINE; CYPROHEPTADINE; PHENYTOIN; POLYMYXIN; PSEUDOMONIC ACID; RETINOID; SULFADIAZINE SILVER; TETRACYCLINE;

BANDAGE; CELL CULTURE; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; EPIDERMOLYSIS BULLOSA; GENETIC ASSOCIATION; HEALTH CARE; HEALTH CARE PERSONNEL; HUMAN; MEDICAL SPECIALIST; NUTRITIONAL REQUIREMENT; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; REVIEW; SKIN CELL; SKIN GRAFT; SKIN TRANSPLANTATION; SUPERINFECTION; TREATMENT INDICATION; TREATMENT OUTCOME; WOUND DRESSING; WOUND HEALING;

EID: 0142218313     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(03)00050-6     Document Type: Article

References (20)

1. Marinkovich M.P. Update on inherited bullous dermatoses. Dermatol Clin. 17:1999;473-485. vii.
2. Fine J.-D., Eady R.A., Bauer E.A., et al. Revised classification system for inherited epidermolysis bullosa report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa . J Am Acad Dermatol. 42:2000;1051-1066.
3. Mellerio J.E. Molecular pathology of the cutaneous basement membrane zone. Clin Exp Dermatol. 24:1999;25-32.
4. Schober-Flores C. Epidermolysis bullosa a nursing perspective . Dermatol Nurs. 11:1999;243-248. 253-6.
5. Fine J.-D., Resnick S.D. Vesiculobullous and neonatal diseases. Schachner L.A., Hansen R.C. Pediatric dermatology, volume 2. 1995;767-809 Churchill Livingstone Inc, New York.
6. Moy J.A., Caldwell-Brown D., Lin A.N., et al. Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa. J Am Acad Dermatol. 22:1990;893-895.
7. Kirsner RS, Orsted H, Wright JB. The role of silver technology in wound healing, part 3: matrix metalloproteinases in normal and impaired wound healing: a potential role of nanocrystalline silver. Wounds 2001;13(suppl C).
8. McGrath J.A., Schofield O.M.V., Mayo B., et al. Epidermolysis bullosa complicated by squamous cell carcinoma report of 10 cases . J Cutan Pathol. 19:1992;116-123.
9. Birge K. Nutrition management of patients with epidermolysis bullosa [see comments]. J Am Diet Assoc. 95:1995;575-579.
10. Wright J.T., Fine J.D., Johnson L. Hereditary epidermolysis bullosa oral manifestations and dental management . Pediatr Dent. 15:1993;242-248.
11. Caldwell-Brown D., Stern R.S., Lin A.N., Carter D.M. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa; Epidermolysis Bullosa Study Group. [see comments] N Engl J Med. 327:1992;163-167.
12. Retief C.R., Malkinson F.D., Pearson R.W. Two familial cases of epidermolysis bullosa simplex successfully treated with tetracycline. [letter] [see comments] [published erratum appears in Arch Dermatol 1999;135:1333] Arch Dermatol. 135:1999;997-998.
13. Veien N.K., Buus S.K. Treatment of epidermolysis bullosa simplex (EBS) with tetracycline [letter; comment]. Arch Dermatol. 136:2000;424-425.
14. Neufeld-Kaiser W., Sybert V.P. Is cyproheptadine effective in the treatment of subjects with epidermolysis bullosa simplex-Dowling-Meara? [letter] Arch Dermatol. 133:1997;251-252.
15. McGrath J.A., Schofield O.M., Ishida-Yamamoto A., et al. Cultured keratinocyte allografts and wound healing in severe recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol. 29:1993;407-419.
16. Witt P.D., Cohen D.T., Mallory S. Use of a permanent acellular dermal allograft in recessive dystrophic epidermolysis bullosa involving the hands. Arch Dermatol. 135:1999;503-506.
17. Williamson D., Coutts P., Sibbald R.G. The role of dermal skin substitutes in the management of hard to heal unusual wounds. Can J Plast Surg. 10:2002;27A-30A.
18. Falabella A.F., Valencia I.C., Eaglstein W.H., Schachner L.A. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol. 136:2000;1225-1230.
19. Eisenberg M., Llewelyn D. Surgical management of hands in children with recessive dystrophic epidermolysis bullosa use of allogeneic composite cultured skin grafts . Br J Plast Surg. 51:1998;608-613.
20. Eady R. Epidermolysis bullosa scientific advances and therapeutic challenges . J Dermatol. 28:2001;638-640.